Stockreport

Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program

Omeros Corporation  (OMER) 
Last omeros corporation earnings: 3/2 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.omeros.com
PDF — OncotoX-AML Effectively Ablated Myeloid Progenitor Cells that Give Rise to AML in Cancer Patients — SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) toda [Read more]